Navigation Links
Regado Biosciences Expands Medical Advisory Board
Date:7/20/2009

ascular Medicine, Cleveland Clinic, Cleveland, Ohio
  • Roxana Mehran, MD, Joint Chief Scientific Officer, Clinical Trial Center, Cardiovascular Research Foundation, New York, New York and Associate Professor of Medicine, Columbia University Medical Center, Columbia University, New York, New York
  • Philippe Menasche, MD, PhD, Professor of Thoracic and Cardiovascular Surgery, University of Paris Descartes and Chief of the Cardiac Surgery Unit, Hopital Europeen Georges Pompidou, Paris, France
    • Lars Wallentin, MD, PhD, Professor of Cardiology, Uppsala Clinical Research Centre, University Hospital, Uppsala, Sweden
    • Harvey White, DSc, Honorary Clinical Professor of Medicine, University of Auckland and Director of Coronary Care and Green Lane Cardiovascular Research Unit, Auckland City Hospital, Auckland, New Zealand

    About Regado Biosciences, Inc.

    Regado Biosciences is pioneering a new therapeutic technology with the creation and development of two-component drug systems. Each system comprises a nuclease-stabilized RNA aptamer that can be controlled directly by its specific and complementary oligonucleotide active control agent. This technology is being applied to injectable antithrombotics, including anticoagulants and antiplatelet agents, a multi-billion dollar market in need of therapeutics with improved safety profiles and a greater degree of therapeutic control. Regado's technology is designed to give physicians the ability to actively and directly control each system's therapeutic effect providing a safe and unique approach to personalized medicine.

    Regado's lead program, the anticoagulant system REG1, consists of two parenteral agents, the first being a potent and highly selective Factor IXa inhibitor (RB006) and the second being its complementary active c
    '/>"/>

    SOURCE Regado Biosciences, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. Regado Biosciences Establishes Medical Advisory Board
    2. Dr. Steven L. Zelenkofske Joins Regado Biosciences as Senior Vice President, Clinical and Medical Affairs and Chief Medical Officer
    3. Regado Biosciences To Present at the 27th Annual J.P. Morgan Healthcare Conference
    4. Ellen McDonald Joins Regado Biosciences as Senior Vice President of Business Operations and Chief Business Officer
    5. Regado Biosciences to Present at the Piper Jaffray Health Care Conference on Tuesday, December 2, 2008
    6. David J. Mazzo, Ph.D., Joins Regado Biosciences as President and CEO
    7. Regado Biosciences REG1 Anticoagulation System Study Results Published in the Journal of Thrombosis and Haemostasis
    8. YM BIOSCIENCES SUBSIDIARY RESOLVES PROPOSED ARBITRATION WITH ONCOSCIENCE AG
    9. YM BIOSCIENCES REPORTS DAIICHI-SANKYO ENROLLS FIRST PATIENTS IN PHASE II, FIRST-LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB
    10. Neurocrine Biosciences to Present at the 8th Annual Needham Life Sciences Conference
    11. Sangamo BioSciences Announces Presentation at the Needham Life Sciences Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/11/2014)... 11, 2014  Researchers have pioneered a revolutionary ... new technology, called Virtual Finger, allows scientists to ... neurons and synapses using the flat surface of ... 3D imaging studies orders of magnitude more efficient, ... level across many areas of experimental biology. The ...
    (Date:7/10/2014)... Understanding the need for better quality and higher ... that currently exists in this area, ChanTest has recently ... validated ion channel and GPCR cell lines. ChanTest’s ... channels control many critical physiological functions throughout the body. ... to treat a variety of human diseases. , ...
    (Date:7/10/2014)... EvoDerma ’s NOOME Anti-Aging Motion has ... now comes with a second treatment cup to help prevent ... new cup is thinner on the edges for a softer ... thin and uneven surfaces on the face, neck and décolleté. ... treatment on areas such as the cheeks and neck, or ...
    (Date:7/10/2014)... PROVO, Utah , July 10, 2014 ... genome annotation and interpretation, today announced an ... sequencing (NGS) analytics for Lineagen,s NextStep Dx ... evaluation of neurodevelopmental and neurological disorders, currently ... chromosomal microarray (CMA) testing service used by ...
    Breaking Biology Technology:Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 2Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 3Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 3Introducing a New Bonus Treatment Cup for EvoDerma’s NOOME Anti-Aging Motion 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 3Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 4
    ... SHANGHAI, China, Aug. 22 /Xinhua-PRNewswire-FirstCall/ --,China-Biotics, Inc. ... leading Chinese firm specializing in the manufacture,research, ... today that it has signed an agreement ... Dairy") (SSE: 600597) to supply probiotics for ...
    ... UniCare,s HealthWave Members with Valuable Local ... ... Health Plan of Kansas,Inc. today announced the opening of its first ... enrollees living in,the Topeka area, the CRC will provide access to ...
    ... - Canadian Biotechnology Company confirms commercial expression levels ... variant and clarifies status of native Apo AI ... Genetics Inc.,(TSX:SBS), a biotechnology company developing a portfolio ... updated a release,issued on July 12, 2007 announcing ...
    Cached Biology Technology:China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd. 2China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd. 3UniCare Unveils Community Resource Center in Topeka to Serve Medicaid Enrollees 2SemBioSys updates Apo AI development program 2SemBioSys updates Apo AI development program 3SemBioSys updates Apo AI development program 4
    (Date:7/14/2014)... at the University of East Anglia have shown how ... growth in cancer patients. , Research published today ... are responsible for the drug,s success in shrinking tumours. ... help develop a synthetic equivalent with anti-cancer properties. ... Complutense de Madridin, Spain. The team used samples of ...
    (Date:7/13/2014)... in women suggests that experiencing one or more stressful ... can slow the body,s metabolism, potentially contributing to weight ... day,s stressors before giving them a meal consisting of ... then measured their metabolic rate how long it ... and took measures of blood sugar, triglycerides, insulin and ...
    (Date:7/11/2014)... Wildlife Conservation Society shows that no-take zones in ... such as lobster, conch, and fish recover from ... areas. , The reporttitled "Review of the Benefits ... literature from no-take areas around the world. The ... recognized expert in marine protected areas and fisheries ...
    Breaking Biology News(10 mins):UEA research reveals how cannabis compound could slow tumour growth 2Weighty issue: Stress and high-fat meals combine to slow metabolism in women 2Weighty issue: Stress and high-fat meals combine to slow metabolism in women 3Weighty issue: Stress and high-fat meals combine to slow metabolism in women 4Belize's lobster, conch, and fish populations rebuild in no-take zones 2
    ... appears to have "snipped off the ends" of its ... that infects human cells, according to research published today ... E. cuniculi , a parasitic fungus commonly found ... humans, has been widely regarded as having the smallest ...
    ... Global Rainmakers, Inc. (GRI), a Puerto Rico based ... today announced the appointment of James Demitrieus as Chief ... firm operations as it diversifies its product offering ... comes to GRI with over 30 years of ...
    ... fan out on Capitol Hill on Tuesday to engage ... to practice communicating the importance of supporting scientific discovery ... The undergraduate and graduate students participating in "Hill ... Molecular Biology, have a number of messages they intend ...
    Cached Biology News:Genomic 'haircut' makes world's tiniest genome even smaller: UBC research 2Global Rainmakers Appoints James M. Demitrieus as Chief Operating Officer 2Global Rainmakers Appoints James M. Demitrieus as Chief Operating Officer 3‘Scientific leaders of the future’ gear up for important talks on Capitol Hill 2‘Scientific leaders of the future’ gear up for important talks on Capitol Hill 3
    ... Lines ,High Quality, Functionally-Validated, Ion Channel Cell ... for having a critical role in nerve ... key function in pain, CNS and the ... been investigated in therapeutic areas, such as ...
    ... PrecisION Ion Channel Cell Lines ,High ... ,Ion channels are well known for having ... function and consequently have a key function ... that modulate ion channels have been investigated ...
    Mouse monoclonal antibody raised against a full length recombinant SLC25A11. NCBI Entrez Gene ID = SLC25A11...
    ... stains proteins in polyacrylamide gel after ... 8 ng of protein) with *CoomassieR-G250. ... processes can be performed in 1.5 ... min), proteins can be seen before ...
    Biology Products: